Regeneron Fair Value
RE
The fair market value of REGN stock is 719.92 USD. Relative to the market price of 1150.19 USD Regeneron Pharmaceuticals is overvalued by 37.4%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Regeneron Valuation
Current REGN share ticker price is 1150.19 USD.
The fair value level of 719.92 USD can be considered as an effective entry point for long-term investors to start investing in REGN stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 37% higher its fair value
Current price is 67% higher its minimum value
Current price is 18% higher its maximum value
Market price:
REGN stock is greatly overvalued
It means the current price may concern as a High Risk Entry Point
Regeneron Pharmaceuticals Inc Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
23.89
2
Median P/E over 5 years
18.22
3
Minimum P/E over 5 years
9.57
4
Earning per share (last 12 months)
39.5 USD
Maximum value
1
x
4
=
943.59 USD
Fair value
2
x
4
=
719.92 USD
Minimum value
3
x
4
=
378.11 USD
Regeneron Pharmaceuticals Inc price metrics
32.2
Annual return (geometric mean)
30.3
Risk (standard deviation) of returns
β
0.1
Beta (volatility compared to market)